Another study found that IL-2 and GM-CSF maintenance therapy induced vitiligo in a striking 43% of patients (21 out of 49), who demonstrated significantly enhanced survival as compared with unaffected patients [6]. The gene discussed is IL2; the disease is vitiligo.